<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3003210649
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Noradrenalin Sintetica 4mg/4ml without disulphite
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        NOREPINEPHRINE BITARTRATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Concentrate for solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        36.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Sintetica SA " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Sintetica SA 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Sintetica SA 
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C01CA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ATC code: C01CA03</p><p>Noradrenalin Sintetica is a medicine that belongs to the group of adrenergic and dopaminergic agents.</p><p>Noradrenalin Sintetica is indicated for the emergency restoration of blood pressure in cases of suddenly decreased blood pressure (acute hypotension).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use</strong><strong> </strong><strong>Noradrenalin Sintetica</strong>:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic (hypersensitive) to noradrenaline preparations or to any of the other ingredients of this medicine (listed in section 6).<em> </em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are hypotensive (have low blood pressure) that has been caused by hypovolaemia (low blood volume).</p><p><strong>Warnings and precautions</strong></p><p><strong>Talk to your doctor or pharmacist before using </strong><strong>Noradrenalin Sintetica</strong>&nbsp; <strong>&nbsp;</strong></p><p>&bull; if you have diabetes</p><p>&bull; if you suffer from high blood pressure</p><p>&bull; if you have an over-active thyroid</p><p>&bull; if you have low levels of oxygen in the blood</p><p>&bull; if you have high levels of carbon dioxide in the blood</p><p>&bull; if you have clots or obstructions in the blood vessels supplying the heart, intestines or other parts of the body</p><p>&bull; if you have low blood pressure following a heart attack</p><p>&bull; if you have a type of angina (chest pain) called Prinzmetal&rsquo;s angina</p><p>&bull; if you are elderly</p><p>&bull; if you have extravasation risk (risk that your blood or lymph escape from their proper vessels into surrounding tissues)</p><p>&bull; if you have major left ventricular dysfunction</p><p>&bull; if you have recently had myocardial infarction (a heart attack)</p><p>&bull;if you have cardiac rhythm disorders (your heart beats too fast, too slow or irregular), you will need a reduced dose.</p><p><strong><em>&nbsp;</em></strong></p><p><strong><em>During the infusion of noradrenaline, your doctor will check continuously your blood pressure and cardiac frequency (heart rate).</em></strong></p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and </strong><strong>Noradrenalin Sintetica &nbsp;</strong><strong>&nbsp;</strong></p><p>Please tell your doctor or nurse if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>&nbsp;</p><p>A number of medicines are known to increase the toxic effects of noradrenaline, such as:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; monoamine oxidase inhibitors (antidepressants)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; tricyclic antidepressants</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; linezolid (an antibiotic)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; anaesthetics (especially anaesthetic gases)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; adrenergic-serotoninergic medicines e.g. used in the treatment of asthma and heart conditions.</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking any medicine.</p><p>Noradrenaline may harm the unborn baby. Your doctor will decide if you should be given Noradrenalin Sintetica Concentrate for solution for infusion.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>None stated.</p><p>&nbsp;</p><p><strong>Important information about some of the ingredients of Noradrenalin Sintetica &nbsp;</strong></p><p>The 2 ml ampoule filled with 1 ml contains 3.3 mg sodium.</p><p>The 5 ml ampoule filled with 4 ml contains 13.3 mg sodium.</p><p>The 10 ml ampoule contains 33 mg sodium.</p><p>Take into consideration if you are on a low-sodium diet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Noradrenalin Sintetica 4mg/4ml will be used to you in hospital by a doctor or nurse. &nbsp;Noradrenaline Sintetica 4mg/4ml without disulphite is administered by pump-controlled infusion (Perfusor, infusion pump). The initial dose of Noradrenalin Sintetica 4 mg/4 ml will depend on your medical condition</p><p>The solution for infusion is generally prepared from 4&nbsp;ml of Noradrenaline Sintetica without disulphite (= 4&nbsp;mg of noradrenaline base) diluted in 1&nbsp;litre of 5% glucose, NaCl 0.9% and glucose saline solution.</p><p>Before any use, carefully check the accuracy of the dilution.</p><p>The smallest effective dose of noradrenaline should be administered for the shortest possible necessary time. Your doctor will determine the correct dose for you. After the initial dose your doctor will assess your response and adjust the dose accordingly.</p><p>&nbsp;</p><p><strong>If you have been given too much</strong><strong> </strong><strong>Noradrenalin Sintetica </strong></p><p>It is unlikely that you will receive too much as this medicine will be given to you in hospital.</p><p>However, talk to your doctor or nurse if you have any concerns.</p><p>Symptoms of overdose are severe high blood pressure, slow heartbeat, violent headache, light sensitivity, pain in the chest, pale colour, intense sweating and vomiting.</p><p>&nbsp;</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Noradrenalin Sintetica can cause side effects, although not everybody gets them.</p><p>The frequency of the adverse reactions cannot be estimated from the available data.</p><p>Tell your doctor immediately if you experience:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which may cause difficulty in swallowing or breathing), feeling that you are going to faint;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; pain and/or swelling at the injection site.</p><p>Tell your doctor as soon as possible if you experience:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; slow heart rate, fast heart rate, palpitations, increase in the contractility of the cardiac muscle, acute cardiac insufficiency</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; abnormal heart rhythm</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; breathing difficulties</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; anxiety, insomnia, confusion, weakness, psychotic state</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; headaches, tremor</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high blood pressure (arterial hypertension), decrease in oxygen supply to some organ (hypoxia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; acute glaucoma</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; cold extremities</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain in the extremities</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nausea, vomiting</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; retention of urine</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; locally: possibility of irritation and necrosis (cell injury, causing death of cells in the tissue) at the injection site.</p><p>&nbsp;</p><p>In case of hypersensitivity or overdose, the following effects may appear more frequently: hypertension (high blood pressure), photophobia (abnormal intolerance to visual perception of light), retrosternal pain (thoracic pain), pharyngeal pain (throat pain), pallor, intense sweating and vomiting.</p><p>&nbsp;</p><p>Your doctor will monitor your blood pressure and blood volume.</p><p><strong>&nbsp;</strong></p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.</p><p>You can also report side effects directly via the National Pharmacovigilance and Drug Safety Center (NPC). By reporting side effects you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Noradrenalin Sintetica can cause side effects, although not everybody gets them.</p><p>The frequency of the adverse reactions cannot be estimated from the available data.</p><p>Tell your doctor immediately if you experience:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which may cause difficulty in swallowing or breathing), feeling that you are going to faint;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; pain and/or swelling at the injection site.</p><p>Tell your doctor as soon as possible if you experience:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; slow heart rate, fast heart rate, palpitations, increase in the contractility of the cardiac muscle, acute cardiac insufficiency</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; abnormal heart rhythm</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; breathing difficulties</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; anxiety, insomnia, confusion, weakness, psychotic state</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; headaches, tremor</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high blood pressure (arterial hypertension), decrease in oxygen supply to some organ (hypoxia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; acute glaucoma</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; cold extremities</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain in the extremities</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nausea, vomiting</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; retention of urine</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; locally: possibility of irritation and necrosis (cell injury, causing death of cells in the tissue) at the injection site.</p><p>&nbsp;</p><p>In case of hypersensitivity or overdose, the following effects may appear more frequently: hypertension (high blood pressure), photophobia (abnormal intolerance to visual perception of light), retrosternal pain (thoracic pain), pharyngeal pain (throat pain), pallor, intense sweating and vomiting.</p><p>&nbsp;</p><p>Your doctor will monitor your blood pressure and blood volume.</p><p><strong>&nbsp;</strong></p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.</p><p>You can also report side effects directly via the National Pharmacovigilance and Drug Safety Center (NPC). By reporting side effects you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Noradrenaline Sintetica</strong> <strong>contains</strong></p><p>The active substance is noradrenaline (as noradrenaline tartrate).</p><p>1 ml concentrate for solution for infusion contains 2 mg noradrenaline tartrate equivalent to 1 mg noradrenaline base.</p><p>&nbsp;</p><p>Noradrenaline Sintetica <em>1 mg/1 ml </em></p><p>2 ml ampoule filled with 1 ml of concentrate for solution for infusion contains 2 mg noradrenaline tartrate equivalent to 1 mg noradrenaline base.</p><p>&nbsp;</p><p>Noradrenaline Sintetica <em>4 mg/4 ml</em></p><p>5 ml ampoule filled with 4 ml of concentrate for solution for infusion contains 8 mg noradrenaline tartrate equivalent to 4 mg noradrenaline base.</p><p><em>&nbsp;</em></p><p>Noradrenaline Sintetica <em>10 mg/10 ml </em></p><p>10 ml ampoule filled with 10 ml of concentrate for solution for infusion contains 20 mg noradrenaline tartrate equivalent to 10 mg noradrenaline base.</p><p>&nbsp;</p><p>The other ingredients are sodium chloride and water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	This medicinal product is presented as a concentrate for solution for infusion. The solution is clear colourless solution.
	It may be supplied in packs of 10 x 1 ml ampoules, 10 x 4 ml ampoules or 10 x 10 ml ampoules.
	Not all pack sizes may be marketed.
	
	------------------------------------------------------------------------------------------------------------
	The following information is intended for medical or healthcare professionals only:

For intravenous use. 
Dilute before use. 
Administer as a diluted solution via a central venous catheter. 
The infusion should be at a controlled rate using either a syringe pump or an infusion pump or a drip counter. 
Incompatibilities 
Infusion solutions containing noradrenaline tartrate have been reported to be incompatible with the following substances: alkalis and oxidising agents, barbiturates, chlorpheniramine, chlorothiazide, nitrofurantoin, novobiocin, phenytoin, sodium bicarbonate, sodium iodide, streptomycin. 

Dilution instructions 
Dilute before use with glucose 5% solution or sodium chloride 9 mg/ml (0.9%) or sodium chloride 9 mg/ml with glucose 5 % solution. 
Noradrenaline Sintetica without disulphite is administered by pump-controlled infusion (Perfusor, infusion pump).
The solution for infusion is generally prepared from 4 ml of Noradrenaline Sintetica without disulphite (= 4 mg of noradrenaline base) diluted in 1 litre of 5% glucose, NaCl 0.9% and glucose saline solution.
Before any use, carefully check the accuracy of the dilution.
The smallest effective dose of noradrenaline should be administered for the shortest possible necessary time.
-	Adults: initial dose 8-12 μg/minute.
	Alternative: 0.5-1 μg/minute with increasing titration until the effective dose is obtained.
	The mean maintenance dose is 2-4 μg/minute.
	The dose may go up to 30 μg/minute in patients with refractory shock.
- 	Children: use in children is not recommended.
Blood pressure must be checked every 2 minutes until the target value is obtained, then every 5 minutes throughout the duration of the infusion. Blood pressure must be adjusted to a value just below the patient’s normal pressure. Avoid any sudden discontinuation of noradrenaline.
The infusion must be given via a venous catheter.

The product is compatible with PVC infusion bags. 
Any unused product or waste material should be disposed of in accordance with local requirements. 
Shelf life after dilution 
Chemical and physical in-use stability has been demonstrated for 24 hours at 25°C when diluted to 4 mg/ml and 40 mg/ml noradrenaline base in sodium chloride 9 mg/ml (0.9%) solution or glucose 5% solution or sodium chloride 9 mg/ml with glucose 5% solution. However, from a microbiological point of view, the product should be used immediately. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder and Manufacturer</p><p>Sintetica S.A</p><p>Vis Penate, 5</p><p>CH-6850 Mendrisio</p><p>Switzerland</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Apr.2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">رمز ATC: C01CA03</p><p dir="RTL">نورادرينالين سينتيتيكا هو عقار يتبع لمجموعة العوامل الأدريانية والدوبامينية.</p><p dir="RTL">يشار باستخدام عقار نورادرينالين سينتيتيكا لاستعادة ضغط الدم في الحالات الطارئة في حالات هبوط ضغط الدم المفاجئ (هبوط ضغط الدم الحاد).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تستخدم عقار <strong>نورادرينالين سينتيتيكا:</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك حساسية (فرط حساسية) لمستحضرات النورادرينالين أو أي مسببات حساسية أخرى في هذا العقار (مدرجة في القسم 6).<em> </em></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من هبوط ضغط الدم (hypotensive) ناجم عن صدمة نقص حجم الدم (hypovolaemia).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL"><strong>تحدث إلى طبيبك أو الصيدلي قبل استخدام عقار نورادرينالين سينتيتيكا </strong></p><p dir="RTL">&bull; إذا كنت تعاني من السكري</p><p dir="RTL">&bull; إذا كنت تعاني من ارتفاع ضغط الدم</p><p dir="RTL">&bull; إذا كنت تعاني من فرط في نشاط الغدة الدرقية</p><p dir="RTL">&bull; إذا كنت تعاني من انخفاض مستويات الأكسجين في الدم</p><p dir="RTL">&bull; إذا كنت تعاني من ارتفاع مستويات ثاني أكسيد الكربون في الدم</p><p dir="RTL">&bull; إذا كنت تعاني من جلطات أو انسدادات في الأوعية الدموية التي تغذي القلب أو الأمعاء أو أجزاء أخرى من الجسم.</p><p dir="RTL">&bull; إذا كان لديك هبوط في ضغط الدم بعد الإصابة بنوبة قلبية</p><p dir="RTL">&bull; إذا كنت تعاني من نوع من الذبحة الصدرية (ألم الصدر) تسمى ذَبْحَةُ برنزميتال</p><p dir="RTL">&bull; إذا كنت كبيراً في السن</p><p dir="RTL">&bull; إذا كنت تعاني من خطر الانصباب الدمي (خطر تسرب الدم أو اللمف من أوعيتها الصحيحة إلى الأنسجة المحيطة)</p><p dir="RTL">&bull; إذا كنت تعاني من اختلال وظيفي في البطين الأيسر الرئيسي.</p><p dir="RTL">&bull; إذا تعرضت مؤخراَ لذبحة قلبية (نوبة قلبية)</p><p dir="RTL">&bull; إذا كنت تعاني من اضطرابات النظم القلبي (دقات القلب سريعة للغاية أو بطيئة للغاية أو غير منتظمة) ، سوف تحتاج إلى جرعة أقل.</p><p dir="RTL"><strong><em>&nbsp;</em></strong></p><p dir="RTL"><strong><em>أثناء حقن عقار النورادرينالين، سيقوم طبيبك بفحص ضغط الدم لديك ومعدل نبض القلب بصورة مستمر (سرعة نبضات القلب).</em></strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>العقاقير الأخرى</strong> <strong>وعقار نورادرينالين سينتيتيكا</strong></p><p dir="RTL">من فضلك أخبر طبيبك أو الممرض إذا كنت تتناول أو تناولت مؤخراً أي أدوية أخرى، يشمل ذلك الأدوية التي يتم الحصول عليها دون وصفة طبية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">هناك عدد من الأدوية المعروفة بأنها تزيد من الآثار السمية للنورادرينالين، مثل:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات أُكسيداز مونوامين (مضادات اكتئاب)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الاكتئاب الثلاثية الحلقات</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp; لينزوليد (مضاد حيوي)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp; أدوية تخدير (خاصة الغازات المخدرة)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الأدرينالية السيروتينية التي تستخدم على سبيل المثال في علاج الربو وأمراض القلب.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">إذا كنت حاملاً أو ترضعين طبيعياً، أو تعتقدين أنك حامل أو تخططين لإنجاب طفل، اطلبي المشورة من طبيبك أو ممرضك قبل تناول هذا الدواء.</p><p dir="RTL">ربما يضر النورادرينالين بالجنين. سوف يقرر طبيبك فيما إذا كان بالإمكان إعطاؤك مركز محلول نورادرينالين سينتيتيكا للحقن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">لا شيء يذكر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات عقار نورادرينالين سينتيتيكا </strong></p><p dir="RTL">تحتوي الأمبولة بسعة 2 مل المعبئة 1 مل على 3.3 ملغم من الصوديوم.</p><p dir="RTL">تحتوي الأمبولة بسعة 5 مل المعبئة 4 مل على 13.3 ملغم من الصوديوم.</p><p dir="RTL">تحتوي الأمبولة بسعة 10 مل على 33 ملغم من الصوديوم.</p><p dir="RTL">يرجى الأخذ بعين الاعتبار إذا كنت تتبع نظام غذائي منخفض الصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيتم إعطاؤك عقار نورادرينالين سينتيتيكا 4 ملغم/ 4 مل في المستشفى بواسطة طبيب أو ممرض.&nbsp; يتم إعطاء عقار نورادرينالين سينتيتيكا&nbsp; 4 ملغم/ 4 مل&nbsp; بدون ديسولفيت بواسطة الحقن المتحكم به (جهاز حقن، مضخة حقن). سوف تعتمد الجرعة الأولية من عقار نورادرينالين سينتيتيكا 4 ملغم/ 4مل على حالتك الصحية.</p><p dir="RTL">يتم تحضير محلول الحقن بوجه عام من 4 مل من نورادرينالين سينتيتيكا بدون ديسولفيت (= 4ملغم من النورادرينالين) مخففة في محلول 1 لتر يحتوي على 5% جلوكوز و 0.9% من كلوريد الصوديوم (NaCl) و محلول جلوكوز ملحي.</p><p dir="RTL">قبل أي استخدام، تحقق بعناية من دقة تخفيف المحلول.</p><p dir="RTL">ينبغي تقديم أصغر جرعة فعالة من النورادرينالين لأقصر فترة زمنية لازمة قدر الإمكان. سيقوم طبيبك بتحديد الجرعة المناسبة لك. بعد الجرعة الأولية سيقوم طبيبك بتقييم استجابتك للعقار وتعديل الجرعة طبقاً لذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تم إعطاؤك الكثير من نورادرينالين سينتيتيكا</strong>&nbsp; <strong>&nbsp;</strong></p><p dir="RTL">من غير المرجح أنك سوف تحصل على الكثير من هذا العقار لأن هذا العقار سيعطى لك في المستشفى.</p><p dir="RTL">مع ذلك، تحدث إلى طبيبك أو الممرض إذا كان لديك أي مخاوف.</p><p dir="RTL">أعراض تناول جرعة مفرطة هي ارتفاع ضغط الدم الشديد، بطء ضربات القلب، صداع شديد، الحساسية للضوء، ألم في الصدر، شحوب اللون، التعرق الشديد والقيء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان لديك أي استفسارات أخرى حول هذا الدواء اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">على غرار جميع الأدوية، يمكن أن يسبب نورادرينالين سينتيتيكا آثاراً جانبية رغم أنها لا تظهر على الجميع.</p><p dir="RTL">لا يمكن تقدير تكرار ظهور الآثار الجانبية من البيانات المتاحة.</p><p dir="RTL">أخبر طبيبك على الفور إذا تعرضت لأي مما يلي:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مفاجئ مثير للحكة، تورم في اليدين أو القدم أو الكاحلين أو الوجه أو الشفتين أو الفم أو الحنجرة (والتي يمكن أن تسبب صعوبة في البلع أو التنفس)، والشعور بأنك سوف تفقد الوعي.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; ألم و/ أو تورم في موقع الحقن.</p><p dir="RTL">أخبر طبيبك في أقرب وقت ممكن أذا تعرضت لأي مما يلي:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; بطء في سرعة نبض القلب، سرعة في نبض القلب، خفقان، زيادة في انقباض عضلة القلب، قصور حاد في القلب.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; عدم انتظام في ضربات القلب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; صعوبات في التنفس</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; قلق، أرق، ارتباك، ضعف، اضطراب ذهني</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; صداع، رعاش</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع ضغط الدم (ارتفاع ضغط الدم الشرياني)، انخفاض في تغذية الأكسجين لبعض أعضاء الجسم (نقص التأكسج)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جلوكوما حادة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; برودة في الأطراف</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الأطراف</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غثيان وقيء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتباس البول</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; موضعياً: إمكانية حدوث تهيج ونخر (إصابة الخلايا، مما يسبب موت الخلايا في الأنسجة) في موقع الحقن.</p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالة فرط التحسس أو تناول جرعة مفرطة، ربما تظهر الآثار التالية بتكرار أكثر: ارتفاع ضغط الدم (hypertension)، عدم تقبل غير طبيعي للإدراك البصري للضوء (رهاب الضوء)، ألم خلف القص (ألم صدري)، ألم بلعومي (ألم في الحلق والحنجرة)، شحوب الوجه، التعرق الشديد والقيء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيقوم طبيبك بمراقبة ضغط الدم وحجم الدم لديك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;&nbsp;</strong></p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا عانيت من أي آثار جانبية، تحدث إلى طبيبك أو الصيدلي أو الممرض، هذا يتضمن أي آثار جانبية غير واردة في هذه النشرة.</p><p dir="RTL">يمكنك أيضاً الإبلاغ عن الآثار الجانبية مباشرة عبر نظام الإبلاغ الوطني. من خلال الإبلاغ عن الأعراض الجانبية يمكنك المساعدة في تقديم مزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ هذا الدواء بعيداً عن أعين ومتناول الأطفال</p><p dir="RTL">لا تستخدم&nbsp; عقار نورادرينالين سينتيتيكا&nbsp; بعد تاريخ انتهاء الصلاحية {شهر/ سنة} المدون على العلبة الكرتونية الخارجية والأمبولة. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من ذلك الشهر.</p><p dir="RTL">لا تحفظ العقار فوق 30 درجة مئوية. لا تقم بحفظه في الثلاجة أو تجميده. يحفظ في العبوة الأصلية لحمايته من الضوء.</p><p dir="RTL">من وجهة نظر ميكروبيولوجية، ينبغي استخدام المنتج مباشرة بعد تخفيفه بالمحلول.</p><p dir="RTL">لا تتخلص من أي أدوية عبر المياه العادمة. اسأل الصيدلي حول كيفية التخلص من الأدوية التي لم تعد بحاجة إلى استخدامها. هذه التدابير من شأنها أن تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ماذا يحتوي عقار نورادرينالين سينتيتيكا </strong></p><p dir="RTL">المادة النشطة هي نورادرينالين (كطرطرات النورادرينالين)</p><p dir="RTL"><em>مركز 1 مل مخفف بمحلول للحقن يحتوي على 2 ملغم من </em>طرطرات النورادرينالين بما يعادل 1 ملغم من النورادرينالين الأساسي.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL">نورادرينالين سينتيتيكا&nbsp; 1 ملغم/ 1 مل</p><p dir="RTL"><em>أمبولة 2 مل معبئة بمركز مخفف بمحلول 1 مل للحقن تحتوي على 2 ملغم من </em>طرطرات النورادرينالين بما يعادل 1 ملغم من النورادرينالين الأساسي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">نورادرينالين سينتيتيكا&nbsp;&nbsp; 4ملغم/ 4 مل</p><p dir="RTL"><em>أمبولة 5&nbsp; مل معبئة بمركز مخفف بمحلول 4 مل للحقن تحتوي <strong>على 8 ملغم من </strong></em><strong>طرطرات النورادرينالين بما يعادل 4 ملغم من النورادرينالين الأساسي.</strong></p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL">نورادرينالين سينتيتيكا&nbsp; 10 ملغم/ 10 مل</p><p dir="RTL"><em>أمبولة 10&nbsp; مل معبئة بمركز مخفف بمحلول 10 مل للحقن تحتوي على 20 ملغم من </em>طرطرات النورادرينالين بما يعادل 10 ملغم من النورادرينالين الأساسي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">المكونات الأخرى هي كلوريد الصوديوم وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدوا عقار&nbsp; نورادرينالين سينتيتيكا ومحتويات العبوة</strong></p><p dir="RTL">يقدم هذا المنتج الدوائي كمركز مخفف بالمحلول للحقن. هذا المحلول هو محلول نظيف وشفاف لا لون له.</p><p dir="RTL">ربما يقدم في عبوات أمبولات 10x1 مل، أمبولات 10x4 مل أو أمبولات 10x10 مل.</p><p dir="RTL">ربما لا تكون أحجام جميع العبوات متوفرة في السوق.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p>------------------------------------------------------------------------------------------------------------</p><p dir="RTL"><strong>المعلومات التالية موجهة للمتخصصين في المجال الطبي أو الرعاية الصحية فقط:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">للاستخدام في الوريد فقط.</p><p dir="RTL">التخفيف بالمحلول قبل الاستخدام.</p><p dir="RTL">يقدم كمحلول مخفف عبر قسطرة وريدية مركزية.</p><p dir="RTL">ينبغي أن يكون الحقن بوتيرة متحكم بها باستخدام إما مضخة حقنة أو مضخة حقن أو جهاز تستيل.</p><p dir="RTL"><strong>تنافر الأدوية</strong></p><p dir="RTL">تم الإبلاغ عن أن محاليل الحقن التي تحتوي على طرطرات النورادرينالين لا تتوافق مع المواد التالية: القلويات والعوامل المؤكسدة، أدوية الباربيتورات، الكلورفينيرامين، الكلوروثيازيد، النتروفورانتوين، النوفوبيوسين، الفينيتوين، بيكربونات الصوديوم، يوديد الصوديوم، الستربتوميسين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تعليمات تخفيف المحلول</strong></p><p dir="RTL">قم بتخفيف المركز قبل الاستخدام بمحلول جلوكوز 5% أو كلوريد الصوديوم 9 ملغم/ مل (0.9%) أو كلوريد الصوديوم 9 ملغم/مل مع محلول جلوكوز 5%</p><p dir="RTL">يتم إعطاء عقار نورادرينالين سينتيتيكا بدون ديسولفيت بواسطة الحقن المتحكم به (جهاز حقن، مضخة حقن).</p><p dir="RTL">يتم تحضير محلول الحقن بوجه عام من 4 مل من نورادرينالين سينتيتيكا بدون ديسولفيت (= 4ملغم من النورادرينالين) مخففة في محلول 1 لتر يحتوي على 5% جلوكوز و 0.9% من كلوريد الصوديوم (NaCl) و محلول جلوكوز ملحي.</p><p dir="RTL">قبل أي استخدام، تحقق بعناية من دقة تخفيف المحلول.</p><p dir="RTL">ينبغي تقديم أصغر جرعة فعالة من النورادرينالين لأقصر فترة زمنية لازمة قدر الإمكان.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; للكبار: الجرعة الأولية 8/12 ميكروغرام/ الدقيقة</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; البديل: 0.5-1 ميكروغرام/ الدقيقة مع زيادة المعايرة حتى الحصول على الجرعة الفعالة.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; الجرعة المستمرة المتوسطة هي 2-4 ميكروغرام/ الدقيقة.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; ربما ترتفع الجرعة إلى 30 ميكروغرام/ الدقيقة لدى المرضى المصابين بصدمة حرون.</p><p dir="RTL">- &nbsp;&nbsp; الأطفال: لا ينصح باستخدام العقار على الأطفال.</p><p dir="RTL">يجب فحص ضغط الدم كل دقيقتين حتى الحصول على القيمة المستهدفة، ثم كل 5 دقائق طيلة فترة الحقن. يجب تعديل ضغط الدم إلى قيمة أقل بقليل من مستوى الضغط الطبيعي للمريض. تجنب وقوع أي توقف مفاجئ في حقن النورادرينالين.</p><p dir="RTL">ينبغي أن يكون الحقن عبر قسطرة وريدية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">هذا العقار متوافق مع أكياس حقن PVC.</p><p dir="RTL">يجب التخلص من أي منتج طبي غير مستعمل أو مواد نفايات وفقاً للمتطلبات المحلية.</p><p dir="RTL"><strong>مدة الصلاحية بعد التخفيف بالمحلول</strong></p><p dir="RTL">تم إثبات الاستقرار الكيميائي والفيزيائي في الاستخدام لمدة 24 ساعة تحت درجة حرارة 25 درجة مئوية عند تخفيفه بالمحلول إلى 4 ملغم/ مل و 40 ملغم/ مل من النورادرينالين الأساسي في محلول كلوريد الصوديوم 9 ملغم/ مل (0.9%) أو محلول جلوكوز 5% أو كلوريد الصوديوم 9 ملغم/ مل مع محلول جلوكوز 5%. مع ذلك، ومن وجهة نظر ميكروبيولوجية، ينبغي استخدام المنتج على الفور.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة الحاملة لترخيص التسويق و المصنعة :</strong></p><p>Sintetica S.A</p><p>Vis Penate, 5</p><p>CH-6850 Mendrisio</p><p>سويسرا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أبريل 2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Noradrenalin Sintetica without disulfiteNoradrenalin Sintetica without disulfite 1 mg/ml concentrate for solution for infusion. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 ml concentrate for solution for infusion contains 2 mg noradrenaline tartrate corresponding to 1 mg noradrenaline base.

Each ampoule containing 1 ml of concentrate for solution for infusion contains 2 mg of noradrenaline tartrate corresponding to 1 mg of noradrenaline base.
Each ampoule containing 4 ml of concentrate for solution for infusion contains 8 mg of noradrenalin tartrate corresponding to 4 mg of noradrenaline base.
Each ampoule containing 10 ml of concentrate for solution for infusion contains 20 mg of noradrenaline tartrate corresponding to 10 mg of noradrenaline base.
 
When diluted as recommended, each ml contains 80 micrograms noradrenaline tartrate equivalent to 40 micrograms noradrenaline base. 

Excipients: 
Each ampoule containing 1 ml of concentrate for solution for infusion contains 0.14 mmol (or 3.3 mg) sodium. 
Each ampoule containing 4 ml of concentrate for solution for infusion contains 0.57 mmol (or 13.2 mg) sodium. 
Each ampoule containing 10 ml of concentrate for solution for infusion contains 1.44 mmol (or 33 mg) sodium. 

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Concentrate for solution for infusion. 
A clear colourless solution.
pH 3.0-4.5.
Osmolarity: approximately 280 mOsm/l.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Indicated for use as an emergency measure in the restoration of blood pressure in cases of acute hypotension.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Noradrenalin Sintetica 4mg/4ml will be used to you in hospital by a doctor or nurse. Noradrenaline Sintetica 4mg/4ml without disulphite is administered by pump-controlled infusion (Perfusor, infusion pump). The initial dose of Noradrenalin Sintetica 4 mg/4 ml will depend on your medical condition The solution for infusion is generally prepared from 4&nbsp;ml of Noradrenaline Sintetica without disulphite (= 4&nbsp;mg of noradrenaline base) diluted in 1&nbsp;litre of 5% glucose, NaCl 0.9% and glucose saline solution. &nbsp;Before any use, carefully check the accuracy of the dilution. The smallest effective dose of noradrenaline should be administered for the shortest possible necessary time. Your doctor will determine the correct dose for you. After the initial dose your doctor will assess your response and adjust the dose accordingly</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                -	Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 
-	Hypotension due to blood volume deficit (hypovolaemia).
-	The use of pressor amines during cyclopropane or halothane anaesthesia may cause serious cardiac arrhythmias. Because of the possibility of increasing risk of ventricular fibrillation, noradrenaline should be used with caution in patients receiving these or any other cardiac sensitising agent or who exhibit profound hypoxia or hypercarbia.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Noradrenalin Sintetica without disulfite Noradrenalin Sintetica without disulfite should only be administered by healthcare professionals who are familiar with its use.</p><p>&nbsp;</p><p><u>Warnings</u></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Noradrenaline should be used only in conjunction with appropriate blood volume replacement.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When infusing noradrenaline, the blood pressure and rate of flow should be checked frequently to avoid hypertension.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The products administrated by injection must always be visually inspected and cannot be used if the presence of particles or a change of colouring is noted.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Extravasation risk:</p><p>The infusion site should be checked frequently for free flow. Care should be taken to avoid extravasation that would cause a necrosis of the tissues surrounding the vein used for injection. Because of the vasoconstriction of the vein wall with increased permeability, there might be some leakage of noradrenaline in the tissues surrounding the infused vein causing a blanching of the tissues which is not due to an obvious extravasation. Hence if blanching occurs, consideration should be given to changing the infusion site to allow the effects of local vasoconstriction to subside.</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treatment of the ischemia due to extravasation:</p><p>During an extravascular leak of the product or an injection besides the vein, a tissue destruction can appear resulting from the vasoconstrictive action of the drug on the blood vessels. The injection zone must be then irrigated as quickly as possible with 10 to 15 ml of physiological salt solution containing 5 to 10 mg phentolamine mesilate. For this purpose, it is necessary to use a syringe provided with a fine needle and to inject locally.</p><p>&nbsp;</p><p><u>Precautions for use</u></p><p>&nbsp;</p><p>Caution and respect of the strict indication must be retained in case of:</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Major left ventricular dysfunction associated with acute hypotension, a careful evaluation of patient&acute;s blood pressure is needed. Supportive therapy should be initiated simultaneously with diagnostic evaluation. Noradrenaline should be reserved for patients with cardiogenic shock and refractory hypotension, in particular those without elevated systemic vascular resistance. It should be started at a dosage of 2 to 4 &micro;g/min and titrated upwards and titrated as necessary. If systemic perfusion or systolic pressure cannot be maintained at &gt; 90 mmHg with a dosage of 15 &micro;g/min, it is unlikely that a further increase will be beneficial.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Particular caution should be observed in patients with coronary, mesenteric or peripheral vascular thrombosis because noradrenaline may increase the ischaemia and extend the area of infarction. Similar caution should be observed in patients with hypotension following myocardial infarction and in patients with Prinzmetal&acute;s variant angina.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Occurrence of heart rhythm disorders during the treatment must lead to a reduction in the dosage.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Caution is advised in patients with hyperthyroidism or diabetes mellitus.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Elderly patients may be especially sensitive to the effects of noradrenaline.</p><p>&nbsp;</p><p>Perfusion of noradrenaline must be performed with continuous monitoring of blood pressure and cardiac frequency.</p><p>Prolonged administration of any potent vasopressor may result in plasma volume depletion which should be continuously corrected by appropriate fluid and electrolyte replacement therapy. If plasma volumes are not corrected, hypotension may recur when the infusion is discontinued, or blood pressure may be maintained at the risk of severe peripheral and visceral vasoconstriction (e.g. decreased renal perfusion) with diminution in blood flow and tissue perfusion with subsequent tissue hypoxia and lactic acidosis and possible ischaemic injury.</p><p>The vasopressor effect (resulting from the adrenergic action in the vessels) can be reduced by the concomitant administration of an alpha-blocking agent whereas the administration of a beta-blocking agent may result in a reduction of the stimulating effect of the product on the heart and in an increase of the hypertensive effect (through reduction of arteriolar dilatation), resulting from beta-1-adrenergic stimulation.</p><p>In cases where it is necessary to administer noradrenaline at the same time as total blood or plasma, the latter must be administered in a separate drip.</p><p>&nbsp;</p><p>Each ampoule containing 1 ml of concentrate for solution for infusion contains 0.14 mmol (or 3.3 mg) sodium.</p><p>Each ampoule containing 4 ml of concentrate for solution for infusion contains 0.57 mmol (or 13.2 mg) sodium.</p><p>Each ampoule containing 10 ml of concentrate for solution for infusion contains 1.44 mmol (or 33 mg) sodium.</p><p>This should be taken into consideration by patients on a controlled sodium diet (see section 2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Inadvisable combinations</u></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Volatile halogen anaesthetics: severe ventricular arrhythmia (increase in cardiac excitability.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Imipramine antidepressants: paroxysmal hypertension with the possibility of arrhythmia (inhibition of the entry of sympathomimetics into sympathetic fibers).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serotoninergic-adrenergic antidepressants: paroxysmal hypertension with the possibility of arrhythmia (inhibition of the entry of sympathomimetics into sympathetic fibers).</p><p>&nbsp;</p><p><u>Combinations requiring precautions for use</u></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-selective MAO inhibitors: increase in the pressor action of the sympathomimetic which is usually moderate. Should only be used under close medical supervision.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Selective MAO-A inhibitors: by extrapolation from non-selective MAO inhibitors, risk of increase in the pressor action. Should only be used under close medical supervision.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Linezolid: by extrapolation from non-selective MAO inhibitors, risk of increase in the pressor action. Should only be used under close medical supervision.</p><p>&nbsp;</p><p>Caution is required when using noradrenaline with beta-blockers as severe hypertension may result.</p><p>Caution is required when using noradrenaline with the following drugs as they may cause increased cardiac effects: thyroid hormones, cardiac glycosides, antiarrhythmic agents.</p><p>Ergot alkaloids or oxytocin may enhance the vasopressor and vasoconstrictive effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>Noradrenalin Sintetica without disulfiteNoradrenalin Sintetica without disulfite may impair placental perfusion and induce fetal bradycardia. It may also exert a contractile effect on the pregnant uterus and lead to fetal asphyxia in late pregnancy. These possible risks to the fetus should therefore be weighed against the potential benefit to the mother.</p><p>&nbsp;</p><p><strong>Breast-feeding</strong></p><p>No information is available on the use of Noradrenalin Sintetica without disulfiteNoradrenalin Sintetica without disulfite in lactation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The frequency of the adverse reactions cannot be estimated from the available data.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Undesirable effect</strong></p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Anxiety, insomnia, confusion, weakness, psychotic state.</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Headache, tremor</p></td></tr><tr><td style="vertical-align:top"><p>Eyes disorders</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Acute glaucoma (very frequent in patients anatomically predisposed with the closing of the iridocorneal angle).</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Tachycardia, bradycardia (probably as a reflex result of blood pressure rising), arrhythmias, palpitations, increase in the contractility of the cardiac muscle resulting from the beta-adrenergic effect on the heart (inotrope and chronotrope), acute cardiac insufficiency.</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Arterial hypertension and tissue hypoxia, ischaemic injury due to potent vasoconstrictor action may result in coldness and paleness of the members and the face.</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Respiratory insufficiency or difficulty, dyspnoea</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Nausea, vomiting.</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>Retention of urine.</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Possibility of irritation and necrosis at the injection site.</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>The continuous administration of vasopressor to maintain blood pressure in absence of blood volume replacement may cause the following symptoms:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe peripheral and visceral vasoconstriction</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in renal blood flow</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in urine production</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hypoxia</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in lactate serum levels.</p><p>&nbsp;</p><p>In case of hypersensitivity or overdose, the following effects may appear more frequently: hypertension, photophobia, retrosternal pain, pharyngeal pain, pallor, intense sweating and vomiting</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the National Pharmacovigilance and Drug Safety Center (NPC).</p><p><em>-To Report any side effect(s):</em></p><ul><li><em>Saudi Arabia: </em></li></ul><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-The National Pharmacovigilance and Drug Safety Center (NPC)</p><ul><li>Fax:+966-11-205-7662</li><li>Call NPC at +966-11-203-8222, Exts: 2317-2356-2353-2354-2334-2340.</li><li>Toll free phone: 8002490000</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: www.sfda.gov.sa/npc</li></ul></td></tr></tbody></table><p><em>&nbsp;</em></p><ul><li><em>Other GCC states: </em></li></ul><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-Please contact the relevant competent authority.<em> </em></p></td></tr></tbody></table><p><em>&nbsp;</em></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdosage may result in severe hypertension, reflex bradycardia, marked increase in peripheral resistance and decreased cardiac output. These may be accompanied by violent headache, photophobia, retrosternal pain, pallor, intense sweating and vomiting. In the event of overdosage, treatment should be withdrawn and appropriate corrective treatment initiated</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Adrenergic and dopaminergic agents, ATC code: C01CA03</p><p><u>Mechanism of action</u></p><p>The vascular effects in the doses normally used clinically result from the simultaneous stimulation of alpha and beta adrenergic receptors in the heart and vascular system. Except in the heart, its action is predominantly on the alpha receptors.</p><p>&nbsp;</p><p><u>Pharmacodynamic effects</u></p><p>This results in an increase in the force (and in the absence of vagal inhibition, in the rate) of myocardial contraction. Peripheral resistance increases, and diastolic and systolic pressures are raised.</p><p>&nbsp;</p><p><u>Clinical efficacy and safety</u></p><p>The increase in blood pressure may cause a reflex decrease in heart rate. Vasoconstriction may result in decreased blood flow in kidneys, liver, skin and smooth muscles. Local vasoconstriction may cause haemostasis and/or necrosis.</p><p>The effect on blood pressure disappears 1-2 minutes after stopping the infusion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Two stereoisomers of noradrenaline exist, the biologically active L-isomer is the one present in noradrenaline 1 mg/ml concentrate for solution for infusion.</p><p>&nbsp;</p><p>Absorption:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Subcutaneous: poor</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Oral: noradrenaline is rapidly inactivated in the gastrointestinal tract following oral administration</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After intravenous administration noradrenaline has a plasmatic half-life of about 1 to 2 minutes.</p><p>Distribution:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Noradrenaline is rapidly cleared from plasma by a combination of cellular reuptake and metabolism. It does not readily cross the blood-brain barrier.</p><p>Biotransformation:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methylation by catechol-o-methyltransferase</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deamination by monoamine oxydase (MAO)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ultimate metabolites from both is 4-hydroxy-3-methoxymandelic acid</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intermediate metabolites include normetanephrine and 3,4-dihydroxymandelic acid.</p><p>Elimination:</p><p>Noradrenaline is mainly eliminated as glucuronide or sulphate conjugates of the metabolites in the urine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Most of the adverse effects attributable to sympathomimetics result from excessive stimulation of the sympathetic nervous system via the different adrenergic receptors.</p><p>&nbsp;</p><p>Noradrenaline may impair placental perfusion and induce fetal bradycardia. It may also exert a contractile effect on the uterus and lead to fetal asphyxia in late pregnancy.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride</p><p>Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Noradrenalin Sintetica without disulfiteNoradrenalin Sintetica without disulfite must not be mixed with other medicinal products except those mentioned in section 6.6.</p><p>Infusion solutions containing noradrenaline tartrate have been reported to be incompatible with the following substances: alkalis and oxidising agents, barbiturates, chlorpheniramine, chlorothiazide, nitrofurantoin, novobiocin, phenytoin, sodium bicarbonate, sodium iodide, streptomycin.</p><p>For compatibility with infusion bags see section 6.6.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
After dilution:
Dilute before use with glucose 5% solution or sodium chloride 9 mg/ml (0.9%) or sodium chloride 9 mg/ml with glucose 5 % solution. 
Noradrenaline Sintetica without disulphite is administered by pump-controlled infusion (Perfusor, infusion pump).
The solution for infusion is generally prepared from 4 ml of Noradrenaline Sintetica without disulphite (= 4 mg of noradrenaline base) diluted in 1 litre of 5% glucose, NaCl 0.9% and glucose saline solution.
Before any use, carefully check the accuracy of the dilution.
The smallest effective dose of noradrenaline should be administered for the shortest possible necessary time.
-	Adults: initial dose 8-12 μg/minute.
	Alternative: 0.5-1 μg/minute with increasing titration until the effective dose is obtained.
	The mean maintenance dose is 2-4 μg/minute.
	The dose may go up to 30 μg/minute in patients with refractory shock.
- 	Children: use in children is not recommended.
Blood pressure must be checked every 2 minutes until the target value is obtained, then every 5 minutes throughout the duration of the infusion. Blood pressure must be adjusted to a value just below the patient’s normal pressure. Avoid any sudden discontinuation of noradrenaline.
The infusion must be given via a venous catheter.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C. Do not refrigerate or freeze.</p><p>Store in original package in order to protect from light.</p><p>&nbsp;</p><p>For storage conditions after dilution of the medicinal product, see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Noradrenalin Sintetica without disulfiteNoradrenalin Sintetica without disulfite 1 mg/1 ml</em></p><p>Type I one point cut clear colorless glass 2 ml ampoules one-point cut.</p><p>Box of 10 ampoules containing 1 ml of concentrate for solution for infusion.</p><p>&nbsp;</p><p><em>Noradrenalin Sintetica without disulfiteNoradrenalin Sintetica without disulfite 4 mg/4 ml</em></p><p>Type I one point cut clear colorless glass 5 ml ampoules one point cut.</p><p>Box of 10 ampoules containing 4 ml of concentrate for solution for infusion.</p><p>&nbsp;</p><p><em>Noradrenalin Sintetica without disulfite 10 mg/10 ml</em></p><p>Type I one point cut clear colorless glass 10 ml ampoules one-point cut.</p><p>Box of 10 ampoules containing 10 ml of concentrate for solution for infusion.</p><p>&nbsp;</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Dilution instructions: </em></p><p>Dilute before use with glucose 5% solution or sodium chloride 9 mg/ml (0.9%) or sodium chloride 9 mg/ml with glucose 5 % solution.</p><p>&nbsp;</p><p>The product is compatible with PVC infusion bags.</p><p>&nbsp;</p><p>Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sintetica S.A
Vis Penate, 5
CH-6850 Mendrisio
Switzerland

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Apr/2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>